SI2938597T1 - Sulfatne soli n-(3-(4-(3-(diizobutilamino)propil)piperazin-1-il)propil)-1h- benzo(d)imidazol-2-amin, njihova priprava in uporaba istega - Google Patents
Sulfatne soli n-(3-(4-(3-(diizobutilamino)propil)piperazin-1-il)propil)-1h- benzo(d)imidazol-2-amin, njihova priprava in uporaba istegaInfo
- Publication number
- SI2938597T1 SI2938597T1 SI201330408A SI201330408A SI2938597T1 SI 2938597 T1 SI2938597 T1 SI 2938597T1 SI 201330408 A SI201330408 A SI 201330408A SI 201330408 A SI201330408 A SI 201330408A SI 2938597 T1 SI2938597 T1 SI 2938597T1
- Authority
- SI
- Slovenia
- Prior art keywords
- propyl
- diisobutylamino
- piperazin
- imidazol
- benzo
- Prior art date
Links
- KLKKWCPJBTXWOV-UHFFFAOYSA-N n-[3-[4-[3-[bis(2-methylpropyl)amino]propyl]piperazin-1-yl]propyl]-1h-benzimidazol-2-amine Chemical class C1CN(CCCN(CC(C)C)CC(C)C)CCN1CCCNC1=NC2=CC=CC=C2N1 KLKKWCPJBTXWOV-UHFFFAOYSA-N 0.000 title 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306690 | 2012-12-27 | ||
| EP13815780.5A EP2938597B1 (en) | 2012-12-27 | 2013-12-27 | Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same |
| PCT/EP2013/078068 WO2014102339A1 (en) | 2012-12-27 | 2013-12-27 | Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2938597T1 true SI2938597T1 (sl) | 2017-03-31 |
Family
ID=47501005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201330408A SI2938597T1 (sl) | 2012-12-27 | 2013-12-27 | Sulfatne soli n-(3-(4-(3-(diizobutilamino)propil)piperazin-1-il)propil)-1h- benzo(d)imidazol-2-amin, njihova priprava in uporaba istega |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US9562018B2 (enExample) |
| EP (1) | EP2938597B1 (enExample) |
| JP (1) | JP6384923B2 (enExample) |
| KR (1) | KR102115060B1 (enExample) |
| CN (1) | CN105008333B (enExample) |
| AU (2) | AU2013369288B2 (enExample) |
| BR (1) | BR112015015474B1 (enExample) |
| CA (1) | CA2895285C (enExample) |
| DK (1) | DK2938597T3 (enExample) |
| ES (1) | ES2605494T3 (enExample) |
| HR (1) | HRP20161612T2 (enExample) |
| HU (1) | HUE030930T2 (enExample) |
| IL (1) | IL239450B (enExample) |
| LT (1) | LT2938597T (enExample) |
| MX (1) | MX363367B (enExample) |
| NZ (1) | NZ708959A (enExample) |
| PL (1) | PL2938597T3 (enExample) |
| PT (1) | PT2938597T (enExample) |
| RS (1) | RS55511B1 (enExample) |
| RU (1) | RU2655454C2 (enExample) |
| SI (1) | SI2938597T1 (enExample) |
| WO (1) | WO2014102339A1 (enExample) |
| ZA (1) | ZA201504521B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS55511B1 (sr) * | 2012-12-27 | 2017-05-31 | Alzprotect | Sulfatne soli n-(3-(4-(3-(diizobutilamino)propil)piperazin-1-il)propil)-1h-benzo[d]imidazol-2-amina, njihova priprema i upotreba |
| WO2016146655A1 (en) | 2015-03-16 | 2016-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Novel 1,4-bis(3-aminopropyl)piperazine derivative and its use |
| TWI744300B (zh) * | 2016-03-23 | 2021-11-01 | 里爾中央醫學中心 | 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途 |
| CN116249693A (zh) * | 2020-10-01 | 2023-06-09 | 雅尔兹普罗泰特公司 | N-(3-(4-(3-(二异丁基氨基)丙基)哌嗪-1-基)丙基)-1H-苯并[d]咪唑-2-胺的琥珀酸盐，其制备及其用途 |
| DK4225306T3 (da) * | 2020-10-07 | 2025-03-24 | Alzprotect | Anvendelse af n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-aminsulfatsalte og solvater heraf til behandling af motorneuronsygdomme og neuromuskulære forbindelseslidelser |
| MX2024007691A (es) | 2021-12-20 | 2024-07-01 | Alzprotect | Uso de sales de succinato de n-(3-(4-(3-(diisobutilamino)propil)pi perazin-1-il)propil)-1h-benzo[d]imidazol-2-amina y solvatos del mismo para el tratamiento de enfermedades de las neuronas motoras y trastornos de la union neuromuscular. |
| US20250205226A1 (en) | 2022-03-25 | 2025-06-26 | Alzprotect | Use of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine salts and solvates thereof for the treatment of sensory neuron diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2674856B1 (fr) * | 1991-04-05 | 1993-07-30 | Esteve Labor Dr | Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments. |
| WO1998056423A1 (fr) * | 1997-06-12 | 1998-12-17 | Transgene S.A. | Nouveaux complexes lipidiques pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique |
| HK1038749A1 (zh) | 1998-09-30 | 2002-03-28 | 纽罗根公司 | 2-哌嗪烷基氨苯并吡咯衍生物:多巴胺受体亚型特异配体 |
| WO2002096431A1 (en) * | 2001-05-25 | 2002-12-05 | The Regents Of The University Of California | Optically active compounds clearing malformed proteins |
| US20040116441A1 (en) * | 2002-10-30 | 2004-06-17 | Pfizer Inc | Methods of using sulfonic acid derivatives |
| EP1581517B1 (en) * | 2002-12-23 | 2007-02-21 | Janssen Pharmaceutica N.V. | Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| ATE524181T1 (de) * | 2004-11-10 | 2011-09-15 | Inst Nat Sante Rech Med | Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen |
| RS55511B1 (sr) * | 2012-12-27 | 2017-05-31 | Alzprotect | Sulfatne soli n-(3-(4-(3-(diizobutilamino)propil)piperazin-1-il)propil)-1h-benzo[d]imidazol-2-amina, njihova priprema i upotreba |
-
2013
- 2013-12-27 RS RS20161055A patent/RS55511B1/sr unknown
- 2013-12-27 DK DK13815780.5T patent/DK2938597T3/en active
- 2013-12-27 HU HUE13815780A patent/HUE030930T2/hu unknown
- 2013-12-27 AU AU2013369288A patent/AU2013369288B2/en active Active
- 2013-12-27 ES ES13815780.5T patent/ES2605494T3/es active Active
- 2013-12-27 JP JP2015550088A patent/JP6384923B2/ja active Active
- 2013-12-27 WO PCT/EP2013/078068 patent/WO2014102339A1/en not_active Ceased
- 2013-12-27 SI SI201330408A patent/SI2938597T1/sl unknown
- 2013-12-27 EP EP13815780.5A patent/EP2938597B1/en active Active
- 2013-12-27 LT LTEP13815780.5T patent/LT2938597T/lt unknown
- 2013-12-27 NZ NZ70895913A patent/NZ708959A/en unknown
- 2013-12-27 BR BR112015015474-3A patent/BR112015015474B1/pt active IP Right Grant
- 2013-12-27 RU RU2015130671A patent/RU2655454C2/ru active
- 2013-12-27 HR HRP20161612TT patent/HRP20161612T2/hr unknown
- 2013-12-27 PT PT138157805T patent/PT2938597T/pt unknown
- 2013-12-27 CA CA2895285A patent/CA2895285C/en active Active
- 2013-12-27 KR KR1020157017192A patent/KR102115060B1/ko active Active
- 2013-12-27 MX MX2015008502A patent/MX363367B/es unknown
- 2013-12-27 PL PL13815780T patent/PL2938597T3/pl unknown
- 2013-12-27 CN CN201380068524.8A patent/CN105008333B/zh active Active
- 2013-12-27 US US14/655,642 patent/US9562018B2/en active Active
-
2015
- 2015-06-16 IL IL239450A patent/IL239450B/en active IP Right Grant
- 2015-06-23 ZA ZA2015/04521A patent/ZA201504521B/en unknown
-
2016
- 2016-12-22 US US15/388,349 patent/US10537569B2/en active Active
-
2018
- 2018-03-28 AU AU2018202218A patent/AU2018202218B2/en active Active
-
2019
- 2019-08-27 US US16/552,436 patent/US10772884B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2022033I1 (el) | Παραγωγα βενζαμιδιου για την αναστολη της δραστικοτητας των abl1, abl2 και bcr-abl1 | |
| HUS2100032I1 (hu) | Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk | |
| ZA201504521B (en) | Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same | |
| ZA201404189B (en) | 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists | |
| ZA201307815B (en) | N-(1,3,4-oxadiazol-2-yl)arylcarboxamides and use thereof as herbicides | |
| HUE042471T2 (hu) | Madárpatogéneket expresszáló, rekombináns, gallid herpeszvírus 3 (MDV 2-es szerotípus) vektorok és alkalmazásuk | |
| SG11201506093SA (en) | N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals | |
| PL3290414T3 (pl) | Sposób otrzymywania n-[5-(3,5-difluorobenzylo)-1h-indazol-3-ilo]-4-(4-metylopiperazyn-1-ylo)-2-(tetrahydropiran-4-yloamino)benzamidu | |
| HUE047849T2 (hu) | PH20 polipeptid variánsok, készítmények, és azok alkalmazása | |
| HUE046104T2 (hu) | Zagy javított diszpergálhatósággal, és ennek alkalmazása | |
| HRP20160250T1 (hr) | Postupak za pripravu 2-(2,3-dimetilfenil)-1-propanala s kloracetonom | |
| IL250606A0 (en) | D2 antagonists, methods of synthesis and methods of use | |
| IL225785A0 (en) | Heterocyclic compounds, compositions comprising the same and uses thereof | |
| HUE054054T2 (hu) | Transz-4-{2-[4-(2,3-diklór-fenil)-piperazin-1-il]-etil}-N,N-dimetilkarbamoil-ciklohexilamin skizofrénia elsõdleges negatív tüneteinek kezelésére | |
| HUE053623T2 (hu) | Vegyületek és azok felhasználása | |
| IL232404A0 (en) | n-(4-quinolinylmethyl)-sulfonamide derivatives and their use as anthelmintics | |
| PL2608789T5 (pl) | Terapeutyczne zastosowania 1-[2-(2,4- dimetylofenylosulfanylo)- fenylo]piperazyny | |
| IL236146A0 (en) | N-[4-quinoline-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, their production and use as medicinal products | |
| EP2813508A4 (en) | HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | |
| EP2763980A4 (en) | BICARBOCYCLIC AND TRICARBOCYCLIC ETHYNYL DERIVATIVES AND USES THEREOF |